Shareholders of Glaxo SmilthKline (GSK) Consumer Nigeria saw their investments in the pharmaceutical company increase by 20.27 per cent after the firm announced its plan to cease operation. GSK Nigeria closed on Thursday that the healthcare company will shut down its operation after its parent company and manufacturer of its vaccines and medicines, GSK UK, decided to terminate their business relationship. GSK UK chose to deal with another local company for the distribution of its products in Nigeria, a move that will send GSK Nigeria out of the market, as the latter doesn’t produce its own drugs. The UK company, prior … Continue reading Why Investors Are Jostling For GSK Nigeria’s Shares Despite Impending Shutdown